Proton Therapy Centers Or High-Capacity Cyclotrons Market Global Report 2026

The proton therapy centers or high-capacity cyclotrons market size has grown rapidly in recent years. It will grow from $1 billion in 2025 to $1.1 billion in 2026 at a compound annual growth rate (CAGR) of 10.4%. The growth in the historic period can be attributed to growing incidence of cancer worldwide, increasing adoption of advanced radiation therapy, rising demand for precision oncology treatments, expanding investments in cancer treatment infrastructure, growing awareness of reduced radiation related side effects.

The proton therapy centers or high-capacity cyclotrons market size is expected to see rapid growth in the next few years. It will grow to $1.65 billion in 2030 at a compound annual growth rate (CAGR) of 10.6%. The growth in the forecast period can be attributed to increasing establishment of proton therapy centers, rising healthcare expenditure on oncology care, expanding reimbursement support for proton therapy, growing demand for treatment of complex tumors, increasing public and private investments in particle therapy facilities. Major trends in the forecast period include growing adoption of pencil beam scanning technology, increasing installation of compact single room proton therapy systems, rising demand for pediatric cancer focused proton therapy, expansion of multi room proton therapy treatment centers, growing preference for organ sparing radiation therapy.

The growing demand for precision radiation therapy is expected to drive the growth of the proton therapy centers or high-capacity cyclotrons market in the coming years. Precision radiation therapy is an advanced cancer treatment approach that delivers targeted radiation doses to tumors while limiting radiation exposure to surrounding healthy tissues. The increasing demand for precision radiation therapy is fueled by the rising incidence of cancer, growing preference for minimally invasive treatment alternatives, and ongoing technological advancements in radiation oncology. Proton therapy centers and high-capacity cyclotrons support the generation of high-energy proton beams needed for accurate tumor targeting, enhancing treatment precision, minimizing side effects, and improving clinical outcomes for cancer patients. For instance, in December 2024, according to ScienceDirect, a Netherlands-based online platform, global demand for radiotherapy is expected to increase to approximately 21.2 million patients by 2050, assuming a 64% radiotherapy utilization rate, representing a significant rise compared with the number of patients treated in 2022. Therefore, the increasing demand for precision radiation therapy is contributing to the growth of the proton therapy centers or high-capacity cyclotrons market.

Leading companies operating in the proton therapy centers or high-capacity cyclotrons market are focusing on developing compact proton therapy systems to improve treatment precision, reduce installation complexity, and expand access to advanced cancer care. Compact proton therapy systems refer to space-efficient proton beam therapy solutions that combine advanced accelerator technologies, imaging systems, and treatment planning capabilities to deliver highly targeted radiation while minimizing exposure to surrounding healthy tissues. For example, in May 2024, IBA (Ion Beam Applications), a Belgium-based provider of proton therapy solutions, signed a contract with Yale New Haven Health and Hartford HealthCare to install its ProteusONE compact proton therapy system in Connecticut, US. The system integrates advanced pencil beam scanning technology and is designed to be upgradeable with DynamicARC beam delivery capabilities after obtaining regulatory clearance. Its compact single-room design, intelligent treatment planning, and precision beam control enable highly accurate cancer treatment while improving clinical workflow and expanding patient access to proton therapy. By combining compact system architecture with advanced proton beam technologies, Proteus®ONE represents an innovative approach to precision radiation therapy.

In September 2024, Mevion Medical Systems Inc., a US-based medical equipment manufacturer, collaborated with NELCO Worldwide to improve proton therapy implementation. The partnership supported the wider adoption of proton therapy by allowing existing linear accelerator (LINAC) treatment vaults to be effectively adapted for the installation of compact proton therapy systems. By integrating advanced radiation shielding technologies with streamlined vault modification solutions, the collaboration enabled healthcare providers to lower deployment timelines and infrastructure expenses while increasing access to proton therapy. NELCO Worldwide is a US-based company specializing in radiation shielding solutions.

Major companies operating in the proton therapy centers or high-capacity cyclotrons market report are Hitachi Ltd., Mitsubishi Electric Corporation, Ion Beam Applications S.A. (IBA), Sumitomo Heavy Industries Ltd., Shinva Medical Instrument Co. Ltd., Mevion Medical Systems Inc., ProTom International Holding Corp., Advanced Cyclotron Systems Inc., Optivus Proton Therapy Inc., Leo Cancer Care, Best Cyclotron Systems Inc., China Institute of Atomic Energy, B dot Medical Inc.

North America was the dominant region in the proton therapy centers or high-capacity cyclotrons market in 2025. Asia-Pacific is expected to be the rapidly growing region in the forecast period. The regions covered in the proton therapy centers or high-capacity cyclotrons market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the proton therapy centers or high-capacity cyclotrons market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

This product will be delivered within 3-5 business days.